Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sudarshan Shivalingaiah"'
Autor:
Mangaiarkarasi S. Asokan, Roshni Florina Joan, Sudhir Babji, Girish Dayma, Prajitha Nadukkandy, Vinutha Subrahmanyam, Archana Pandey, Girish Malagi, Pooja Arya, Vibhuti Mahajan, Jayateerth Bhavikatti, Ketakee Pawar, Aishwarya Thorat, Priyanki Shah, Ramakrishna B. Goud, Bishnudeo Roy, Shon Rajukutty, Sushil Immanuel, Dhiraj Agarwal, Sankhanil Saha, Akshatha Shivaraj, Patricia Panikulam, Rajeshwari Shome, Shah-E-Jahan Gulzar, Anusmrithi U. Sharma, Ajinkya Naik, Shruti Talashi, Madhuri Belekar, Ritu Yadav, Poornima Khude, Mamatha V, Sudarshan Shivalingaiah, Urmila Deshmukh, Chinmayee Bhise, Manjiri Joshi, Leeberk Raja Inbaraj, Sindhulina Chandrasingh, Aurnab Ghose, Colin Jamora, Anandi S. Karumbati, Varadharajan Sundaramurthy, Avita Johnson, Naveen Ramesh, Nirutha Chetan, Chaitra Parthiban, Asma Ahmed, Srabanti Rakshit, Vasista Adiga, George D'souza, Vinay Rale, Carolin Elizabeth George, Jacob John, Anand Kawade, Akanksha Chaturvedi, Anu Raghunathan, Mary Dias, Anand Bhosale, Padinjat Raghu, L.S. Shashidhara, Annapurna Vyakarnam, Vineeta Bal, Gagandeep Kang, Satyajit Mayor
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 22, Iss , Pp 100361- (2024)
Summary: Background: There are limited global data on head-to-head comparisons of vaccine platforms assessing both humoral and cellular immune responses, stratified by pre-vaccination serostatus. The COVID-19 vaccination drive for the Indian populati
Externí odkaz:
https://doaj.org/article/97b23212b93e4d7e94207bd587e0f140
Autor:
Srabanti Rakshit, Sudhir Babji, Chaitra Parthiban, Ramya Madhavan, Vasista Adiga, Sharon Eveline J, Nirutha Chetan Kumar, Asma Ahmed, Sudarshan Shivalingaiah, Nandini Shashikumar, Mamatha V, Avita Rose Johnson, Naveen Ramesh, Ramkrishna Goud B, Mangaiarkarasi Asokan, Satyajit Mayor, Gagandeep Kang, George D’souza, Mary Dias, Annapurna Vyakarnam
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-18 (2023)
Abstract Detailed characterisation of immune responses induced by COVID-19 vaccines rolled out in India: COVISHIELDTM (CS) and COVAXIN® (CO) in a pre-exposed population is only recently being discovered. We addressed this issue in subjects who recei
Externí odkaz:
https://doaj.org/article/30f5306b692f49f4b2a280fbe4ebd644
Autor:
Srabanti Rakshit, Vasista Adiga, Asma Ahmed, Chaitra Parthiban, Nirutha Chetan Kumar, Pratibha Dwarkanath, Sudarshan Shivalingaiah, Srishti Rao, George D’Souza, Mary Dias, Thomas J. A. Maguire, Katie J. Doores, Martijn Zoodsma, Busranur Geckin, Prokar Dasgupta, Sudhir Babji, Krista E. van Meijgaarden, Simone A. Joosten, Tom H. M. Ottenhoff, Yang Li, Mihai G. Netea, Kenneth D. Stuart, Stephen C. De Rosa, M. Juliana McElrath, Annapurna Vyakarnam
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
This proof-of-concept study tested if prior BCG revaccination can qualitatively and quantitively enhance antibody and T-cell responses induced by Oxford/AstraZeneca ChAdOx1nCoV-19 or COVISHIELD™, an efficacious and the most widely distributed vacci
Externí odkaz:
https://doaj.org/article/bc79bf4b1a8a4e5c9ddd03b87afafc55
Autor:
Srabanti Rakshit, Vasista Adiga, Asma Ahmed, Chaitra Parthiban, Nirutha Kumar, Sudarshan Shivalingaiah, Srishti Rao, George D'Souza, Pratibha Dwarkanath, Mary Dias, Thomas Maguire, Katie Doores, Prokar Dasgupta, Sudhir Babji, Tom Ottenhoff, Kenneth Stuart, Stephen De Rosa, M. Juliana McElrath, Annapurna Vyakarnam
This study tested if prior BCG revaccination can further boost immune responses subsequently induced by an otherwise efficacious Oxford/AstraZeneca ChAdOx1nCoV-19 vaccine, referred to as COVISHIELDTM in India. We compared COVISHIELDTM induced longitu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e15e2b7cea35bb8bfc613fc0823dea39
https://doi.org/10.21203/rs.3.rs-1395683/v1
https://doi.org/10.21203/rs.3.rs-1395683/v1
Autor:
Vinutha Chandrakanth, Sudarshan Shivalingaiah, Lava Chikkappaiah, Harish Nayaka Mysore Annaiah
Publikováno v:
Sugar Tech. 21:388-397
Jaggery was fortified with Elettaria cardamomum at 0.05%, 0.1% and 0.2% (w/v) of Co 86032, Co 419 and Co 62175 sugarcane varieties and was evaluated for physical and chemical characteristics and in vitro antioxidant capacity, viz. 1,1-diphenyl-2-picr
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.